title: NIH-defined graft-versus-host disease after reduced intensity or myeloablative conditioning in patients with acute myeloid leukemia.
authors.forename: T H
authors.initials: TH
authors.lastname: Terwey
authors.forename: A
authors.initials: A
authors.lastname: Vega-Ruiz
authors.forename: P G
authors.initials: PG
authors.lastname: Hemmati
authors.forename: P
authors.initials: P
authors.lastname: Martus
authors.forename: E
authors.initials: E
authors.lastname: Dietz
authors.forename: P
authors.initials: P
authors.lastname: le Coutre
authors.forename: G
authors.initials: G
authors.lastname: Massenkeil
authors.forename: B
authors.initials: B
authors.lastname: Dörken
authors.forename: R
authors.initials: R
authors.lastname: Arnold
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006086:Graft vs Host Disease / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015994:Incidence; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000401:mortality / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D019172:Transplantation Conditioning; D055815:Young Adult